Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Cold Spring Harb Perspect Med. 2022 Dec 1;12(12):a041154. doi: 10.1101/cshperspect.a041154.
Endothelial colony-forming cells (ECFCs) are progenitor cells that can give rise to colonies of highly proliferative vascular endothelial cells (ECs) with clonal expansion and in vivo blood vessel-forming potential. More than two decades ago, the identification of ECFCs in human peripheral blood created tremendous opportunities as having a clinically accessible source of autologous ECs could facilitate meaningful therapies with the potential to impact multiple vascular diseases. Nevertheless, until recently, the field of endothelial progenitor cells has been plagued with ambiguities and controversies, and reaching a consensus on the definition of ECFCs has not been straightforward. Moreover, although the basic phenotypical and functional characteristics of cultured ECFCs are now well established, some fundamental questions such as the origin of ECFCs and their physiological roles in health and disease remain incompletely understood. Here, I highlight some critical studies that have shaped our current understanding of ECFCs in humans. Insights into the biological attributes of ECFCs are essential for facilitating the clinical translation of their therapeutic potential.
内皮祖细胞(endothelial colony-forming cells,ECFCs)是一种祖细胞,能够产生具有克隆扩增和体内血管生成潜能的高度增殖性血管内皮细胞(endothelial cells,ECs)集落。二十多年前,在人外周血中鉴定出 ECFCs,为其作为自体 ECs 的临床可及来源提供了巨大的机会,这可能为多种血管疾病的治疗带来有意义的影响。然而,直到最近,内皮祖细胞领域一直存在着诸多模糊性和争议,对于 ECFCs 的定义尚未达成明确共识。此外,尽管培养的 ECFCs 的基本表型和功能特征现在已经得到很好的确立,但一些基本问题,如 ECFCs 的起源及其在健康和疾病中的生理作用,仍不完全清楚。在这里,我将重点介绍一些对我们目前对人类 ECFCs 的理解产生重大影响的研究。了解 ECFCs 的生物学特性对于促进其治疗潜力的临床转化至关重要。